Wassim Abou-Kheir, Ph.D. - Publications

2007 Yeshiva University, New York, NY, United States 
Cell Biology

3/49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Dovas A, Gevrey JC, Grossi A, Park H, Abou-Kheir W, Cox D. Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. Journal of Cell Science. 122: 3873-82. PMID 19808890 DOI: 10.1242/jcs.051755  0.36
2008 Abou-Kheir W, Isaac B, Yamaguchi H, Cox D. Membrane targeting of WAVE2 is not sufficient for WAVE2-dependent actin polymerization: a role for IRSp53 in mediating the interaction between Rac and WAVE2. Journal of Cell Science. 121: 379-90. PMID 18198193 DOI: 10.1242/jcs.010272  0.36
2005 Kheir WA, Gevrey JC, Yamaguchi H, Isaac B, Cox D. A WAVE2-Abi1 complex mediates CSF-1-induced F-actin-rich membrane protrusions and migration in macrophages. Journal of Cell Science. 118: 5369-79. PMID 16280551 DOI: 10.1242/jcs.02638  0.44
Low-probability matches
2020 Daouk R, Bahmad HF, Saleh E, Monzer A, Ballout F, Kadara H, Abou-Kheir W. Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets. Plos One. 15: e0237442. PMID 32790767 DOI: 10.1371/journal.pone.0237442  0.01
2020 Bahmad HF, Peng W, Zhu R, Ballout F, Monzer A, Elajami MK, Kobeissy F, Abou-Kheir W, Mechref Y. Protein Expression Analysis of an In Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets. Journal of Personalized Medicine. 10. PMID 32784957 DOI: 10.3390/jpm10030083  0.01
2020 Bahmad HF, Abou-Kheir W. Crosstalk between COVID-19 and prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 32709978 DOI: 10.1038/s41391-020-0262-y  0.01
2020 Al Matari N, Deeb G, Mshiek H, Sinjab A, Kadara H, Abou-Kheir W, Mhanna R. Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro Models. Molecules (Basel, Switzerland). 25. PMID 32503108 DOI: 10.3390/molecules25112595  0.01
2020 Abou-Kheir W, Mukherji D, Hadadeh O, Saleh E, Bahmad HF, Kanso M, Khalifeh M, Shamseddine A, Tamraz S, Jaafar R, Dagher C, Khalifeh I, Faraj W. CYR61/CCN1 expression in resected pancreatic ductal adenocarcinoma: A retrospective pilot study of the interaction between the tumors and their surrounding microenvironment. Heliyon. 6: e03842. PMID 32395647 DOI: 10.1016/j.heliyon.2020.e03842  0.01
2020 Msheik H, Azar J, El Sabeh M, Abou-Kheir W, Daoud G. HTR-8/SVneo: A model for epithelial to mesenchymal transition in the human placenta. Placenta. 90: 90-97. PMID 32056558 DOI: 10.1016/j.placenta.2019.12.013  0.01
2020 Bahmad HF, Elajami MK, El Zarif T, Bou-Gharios J, Abou-Antoun T, Abou-Kheir W. Drug repurposing towards targeting cancer stem cells in pediatric brain tumors. Cancer Metastasis Reviews. PMID 31919619 DOI: 10.1007/s10555-019-09840-2  0.01
2019 Bahmad HF, Darwish B, Dargham KB, Machmouchi R, Dargham BB, Osman M, Khechen ZA, El Housheimi N, Abou-Kheir W, Chamaa F. Role of MicroRNAs in Anesthesia-Induced Neurotoxicity in Animal Models and Neuronal Cultures: a Systematic Review. Neurotoxicity Research. PMID 31707631 DOI: 10.1007/s12640-019-00135-6  0.01
2019 Malaeb W, Bahmad HF, Abou-Kheir W, Mhanna R. The sulfation of biomimetic glycosaminoglycan substrates controls binding of growth factors and subsequent neural and glial cell growth. Biomaterials Science. PMID 31407727 DOI: 10.1039/c9bm00964g  0.01
2019 Darwish B, Chamaa F, Al-Chaer ED, Saadé NE, Abou-Kheir W. Intranigral Injection of Endotoxin Suppresses Proliferation of Hippocampal Progenitor Cells. Frontiers in Neuroscience. 13: 687. PMID 31333405 DOI: 10.3389/fnins.2019.00687  0.01
2019 Ismail JN, Badini S, Frey F, Abou-Kheir W, Shirinian M. Tet Is Expressed in Midline Glia and Is Required for Proper Axonal Development. Frontiers in Cellular Neuroscience. 13: 252. PMID 31213988 DOI: 10.3389/fncel.2019.00252  0.01
2019 Bahmad HF, Chamaa F, Assi S, Chalhoub RM, Abou-Antoun T, Abou-Kheir W. Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier. Frontiers in Molecular Neuroscience. 12: 131. PMID 31191243 DOI: 10.3389/fnmol.2019.00131  0.01
2019 Daouk R, Hassane M, Bahmad HF, Sinjab A, Fujimoto J, Abou-Kheir W, Kadara H. Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From -Deficient Murine Lung Adenocarcinoma With Somatic Mutations. Frontiers in Oncology. 9: 207. PMID 31001473 DOI: 10.3389/fonc.2019.00207  0.01
2019 Bodgi L, Bahmad HF, Araji T, Al Choboq J, Bou-Gharios J, Cheaito K, Zeidan YH, Eid T, Geara F, Abou-Kheir W. Assessing Radiosensitivity of Bladder Cancer : A 2D vs. 3D Approach. Frontiers in Oncology. 9: 153. PMID 30941305 DOI: 10.3389/fonc.2019.00153  0.01
2019 Cheaito KA, Bahmad HF, Hadadeh O, Saleh E, Dagher C, Hammoud MS, Shahait M, Mrad ZA, Nassif S, Tawil A, Bulbul M, Khauli R, Wazzan W, Nasr R, Shamseddine A, ... ... Abou-Kheir W, et al. EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence? Frontiers in Oncology. 9: 131. PMID 30915272 DOI: 10.3389/fonc.2019.00131  0.01
2019 Bahmad HF, Samman H, Monzer A, Hadadeh O, Cheaito K, Abdel-Samad R, Hayar B, Pisano C, Msheik H, Liu YN, Darwiche N, Abou-Kheir W. The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem-like cells. Molecular Carcinogenesis. PMID 30883933 DOI: 10.1002/mc.23004  0.01
2018 Bahmad HF, Mouhieddine TH, Chalhoub RM, Assi S, Araji T, Chamaa F, Itani MM, Nokkari A, Kobeissy F, Daoud G, Abou-Kheir W. The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma. Oncotarget. 9: 33549-33561. PMID 30323898 DOI: 10.18632/oncotarget.26088  0.01
2018 Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, El-Hajj A, Mukherji D, Liu YN, Daoud G, Abou-Kheir W. Sphere-Formation Assay: Three-Dimensional Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells. Frontiers in Oncology. 8: 347. PMID 30211124 DOI: 10.3389/fonc.2018.00347  0.01
2018 Siu MK, Abou-Kheir W, Yin JJ, Chang YS, Barrett B, Suau F, Casey O, Chen WY, Fang L, Hynes P, Hsieh YY, Liu YN, Huang J, Kelly K. Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Oncotarget. 9: 32403. PMID 30190798 DOI: 10.18632/oncotarget.26020  0.01
2018 Chamaa F, Bahmad HF, Makkawi AK, Chalhoub RM, Al-Chaer ED, Bikhazi GB, Nahas Z, Abou-Kheir W. Nitrous Oxide Induces Prominent Cell Proliferation in Adult Rat Hippocampal Dentate Gyrus. Frontiers in Cellular Neuroscience. 12: 135. PMID 29867368 DOI: 10.3389/fncel.2018.00135  0.01
2018 Tsai YC, Chen WY, Abou-Kheir W, Zeng T, Yin JJ, Bahmad H, Lee YC, Liu YN. Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2. Biochimica Et Biophysica Acta. PMID 29477409 DOI: 10.1016/j.bbadis.2018.02.016  0.01
2018 Tsai YC, Zeng T, Abou-Kheir W, Yeh HL, Yin JJ, Lee YC, Chen WY, Liu YN. Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer. Molecular Cancer. 17: 42. PMID 29455655 DOI: 10.1186/s12943-018-0785-1  0.01
2018 Chamaa F, Bitar L, Darwish B, Saade NE, Abou-Kheir W. Intracerebroventricular injections of endotoxin (ET) reduces hippocampal neurogenesis. Journal of Neuroimmunology. 315: 58-67. PMID 29306407 DOI: 10.1016/j.jneuroim.2017.12.013  0.01
2017 Ghazale H, Ramadan N, Mantash S, Zibara K, El-Sitt S, Darwish H, Chamaa F, Boustany RM, Mondello S, Abou-Kheir W, Soueid J, Kobeissy F. Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post-Traumatic brain injury. Behavioural Brain Research. PMID 29126932 DOI: 10.1016/j.bbr.2017.11.007  0.01
2017 Bilani N, Bahmad H, Abou-Kheir W. Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms. Frontiers in Pharmacology. 8: 145. PMID 28377721 DOI: 10.3389/fphar.2017.00145  0.01
2017 Bahmad H, Hadadeh O, Chamaa F, Cheaito K, Darwish B, Makkawi AK, Abou-Kheir W. Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma. Frontiers in Molecular Neuroscience. 10: 50. PMID 28293168 DOI: 10.3389/fnmol.2017.00050  0.01
2017 Katerji M, Barada K, Jomaa M, Kobeissy F, Makkawi AK, Abou-Kheir W, Usta J. Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients. Frontiers in Molecular Neuroscience. 10: 10. PMID 28197071 DOI: 10.3389/fnmol.2017.00010  0.01
2017 Abou-Kheir W, Barrak J, Hadadeh O, Daoud G. HTR-8/SVneo cell line contains a mixed population of cells. Placenta. 50: 1-7. PMID 28161053 DOI: 10.1016/j.placenta.2016.12.007  0.01
2016 Daoud G, Monzer A, Bahmad H, Chamaa F, Hamdar L, Mouhieddine TH, Shayya S, Eid A, Kobeissy F, Liu YN, Abou-Kheir W. Primary versus castration‑resistant prostate cancer: modeling through novel murine prostate cancer cell lines. Oncotarget. PMID 27036046 DOI: 10.18632/oncotarget.8436  0.01
2015 Mouhieddine TH, Nokkari A, Itani MM, Chamaa F, Bahmad H, Monzer A, El-Merahbi R, Daoud G, Eid A, Kobeissy FH, Abou-Kheir W. Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells. Frontiers in Neuroscience. 9: 442. PMID 26635517 DOI: 10.3389/fnins.2015.00442  0.01
2015 Agarwal S, Hynes PG, Tillman HS, Lake R, Abou-Kheir WG, Fang L, Casey OM, Ameri AH, Martin PL, Yin JJ, Iaquinta PJ, Karthaus WR, Clevers HC, Sawyers CL, Kelly K. Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors. Cell Reports. 13: 2147-58. PMID 26628377 DOI: 10.1016/j.celrep.2015.10.077  0.01
2015 Chamaa F, Sweidan W, Nahas Z, Saade N, Abou-Kheir W. Thalamic Stimulation in Awake Rats Induces Neurogenesis in the Hippocampal Formation. Brain Stimulation. PMID 26460201 DOI: 10.1016/j.brs.2015.09.006  0.01
2015 Abou-Kheir W, Eid A, El-Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. Plos One. 10: e0139939. PMID 26430881 DOI: 10.1371/journal.pone.0139939  0.01
2015 Nokkari A, Mouhieddine TH, Itani MM, Abou-Kheir W, Daoud G, Zhu R, Mechref Y, Soueid J, Al Hariri M, Mondello S, Jaffa AA, Kobeissy F. Correction: Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. Plos One. 10: e0136345. PMID 26288275 DOI: 10.1371/journal.pone.0136345  0.01
2015 Nokkari A, Mouhieddine TH, Itani MM, Abou-Kheir W, Daoud G, Zhu R, Meshref Y, Soueid J, Al Hariri M, Mondello S, Jaffa AA, Kobeissy F. Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. Plos One. 10: e0128601. PMID 26047500 DOI: 10.1371/journal.pone.0128601  0.01
2015 Chen WY, Liu SY, Chang YS, Yin JJ, Yeh HL, Mouhieddine TH, Hadadeh O, Abou-Kheir W, Liu YN. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget. 6: 441-57. PMID 25436980  0.01
2015 Ghantous CM, Azrak Z, Hanache S, Abou-Kheir W, Zeidan A. Differential Role of Leptin and Adiponectin in Cardiovascular System International Journal of Endocrinology. 2015. DOI: 10.1155/2015/534320  0.01
2014 El-Merahbi R, Liu YN, Eid A, Daoud G, Hosry L, Monzer A, Mouhieddine TH, Hamade A, Najjar F, Abou-Kheir W. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells. Plos One. 9: e112453. PMID 25380390 DOI: 10.1371/journal.pone.0112453  0.01
2014 Siu MK, Abou-Kheir W, Yin JJ, Chang YS, Barrett B, Suau F, Casey O, Chen WY, Fang L, Hynes P, Hsieh YY, Liu YN, Huang J, Kelly K. Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Oncotarget. 5: 3770-84. PMID 25004126  0.01
2013 Eid S, Abou-Kheir W, Sabra R, Daoud G, Jaffa A, Ziyadeh FN, Roman L, Eid AA. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy Journal of Biological Regulators and Homeostatic Agents. 27: 693-703. PMID 24152838  0.01
2013 Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms Oncogene. 32: 296-306. PMID 22370643 DOI: 10.1038/onc.2012.58  0.01
2012 Casey OM, Fang L, Hynes PG, Abou-Kheir WG, Martin PL, Tillman HS, Petrovics G, Awwad HO, Ward Y, Lake R, Zhang L, Kelly K. TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. Plos One. 7: e41668. PMID 22860005 DOI: 10.1371/journal.pone.0041668  0.01
2012 Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Molecular and Cellular Biology. 32: 941-53. PMID 22203039 DOI: 10.1128/MCB.06306-11  0.01
2011 Abou-Kheir W, Hynes PG, Martin P, Yin JJ, Liu YN, Seng V, Lake R, Spurrier J, Kelly K. Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity. Plos One. 6: e26112. PMID 22022528 DOI: 10.1371/journal.pone.0026112  0.01
2011 Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. The American Journal of Pathology. 179: 422-35. PMID 21703421 DOI: 10.1016/j.ajpath.2011.03.035  0.01
2010 Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model. Stem Cells (Dayton, Ohio). 28: 2129-40. PMID 20936707 DOI: 10.1002/stem.538  0.01
Hide low-probability matches.